DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice.

[1]  J. Feger,et al.  Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations , 2017, Radiopaedia.org.

[2]  P. Kempster,et al.  Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. , 2016, Brain : a journal of neurology.

[3]  Nan Yan,et al.  Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice , 2015, The Journal of Immunology.

[4]  Nan Yan,et al.  Cytosolic Nuclease TREX1 Regulates Oligosaccharyltransferase Activity Independent of Nuclease Activity to Suppress Immune Activation. , 2015, Immunity.

[5]  J. Schoggins.  A Sense of Self: RIG-I's Tolerance to Host RNA. , 2015, Immunity.

[6]  Y. Crow,et al.  Aicardi–Goutières syndrome and the type I interferonopathies , 2015, Nature Reviews Immunology.

[7]  T. Hollis,et al.  Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease , 2015, Proceedings of the National Academy of Sciences.

[8]  Quanzhen Li,et al.  Cutting Edge: AIM2 and Endosomal TLRs Differentially Regulate Arthritis and Autoantibody Production in DNase II–Deficient Mice , 2015, The Journal of Immunology.

[9]  Nan Yan,et al.  Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes , 2012, Nature Immunology.

[10]  D. Stetson,et al.  Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. , 2012, Immunity.

[11]  D. Roopenian,et al.  NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas. , 2008, Cancer research.

[12]  T. Heidmann,et al.  Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity , 2008, Cell.

[13]  D. Barnes,et al.  Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease , 2007, Cell.

[14]  J. Lieberman,et al.  Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus , 2007, Nature Genetics.

[15]  S. Nelson,et al.  C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy , 2007, Nature Genetics.

[16]  Keiichiro Suzuki,et al.  Regulation of B1 cell migration by signals through Toll-like receptors , 2006, The Journal of experimental medicine.

[17]  Quanzhen Li,et al.  A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Barnes,et al.  Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis , 2004, Molecular and Cellular Biology.

[19]  Dan J. Mazur,et al.  Identification and Expression of the TREX1 and TREX2 cDNA Sequences Encoding Mammalian 3′→5′ Exonucleases* , 1999, The Journal of Biological Chemistry.

[20]  J. Sgouros,et al.  A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein , 1999, The EMBO journal.